Arsenic trioxide (Phenasen)
Arsenic trioxide
Key Oncologics (Pty) Ltd
Registration
- Applicant
- Key Oncologics (Pty) Ltd
- Registrations
- 1
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Phenasen 10 mg/10 ML EACH 10 ml VIAL CONTAINS: ARSENIC TRIOXIDE 10,0 mg | 10 mg/10 ml | 52001952/26/0019 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Arsenic
- when intended for injection;
- except in oral dosage form. (S1, S2)
Consolidated Schedules 06 July 2026, lines 5346 to 5350
S2: Arsenic
- except in oral dosage forms containing the equivalent of 0,01 percent or less of arsenic trioxide; (S1)
- except when intended for injection. (S4)
Consolidated Schedules 06 July 2026, lines 1610 to 1614
S1: Arsenic
- in oral dosage forms in concentrations equivalent to 0,01 percent or less of arsenic trioxide; (S2)
- except when intended for injection. (S4)
Consolidated Schedules 06 July 2026, lines 138 to 142
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
No structure available
This product's active ingredient could not be matched to a single known compound.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.